ВУЗ: Не указан
Категория: Не указан
Дисциплина: Не указана
Добавлен: 04.10.2020
Просмотров: 2481
Скачиваний: 11
141
Литература
on Offspring Growth From Birth Through 3 Years of Age», Neurotoxicology and Teratology 14: 407—14 (1992);
Barr H.M. et al.
«Infant Size at 8 Months of Age: Relationship to Maternal Use of Alcohol, Nicotine, and Caffeine
During Pregnancy», Pediatrics 74: 336—41 (1984);
Fried P.A., Watkinson B.
(1990), см. № 31;
Streissguth A.P.
et al.
(1989), см. № 24;
Cornelius M.D. et al.
(1990), см. № 17;
Kline J. et al.
(1987), см. № 17;
Pried P.A.
(1995),
см. № 38.
14.
МАРИХУАНА И ИММУННАЯ СИСТЕМА
1. Parents Resource Institute for Drug Education, Marijuana and Cocaine, Atlanta: PRIDE (1990).
2 .
Ernest D.
Preate, Blowing Away the Marijuana Smokescreen, Scranton: Pennsylvania Office of Attorney
General (no date), p. 2.
3.
Spence W.R.
Marijuana: Its Effects and Hazards, Waco: Health Edco (no date).
4. Voth E.A. The International Drug Strategy Institute Position Paper on the Medical Applications of Marijuana,
Omaha: Drug Watch International (undated).
5. Drug Watch International, By Any Modern Medical Standard, Marijuana is No Medicine, Omaha (undated).
6.
Nahas G.G.
Marihuana%Deceptive Weed, New York: Raven Press (1973).
7.
Nahas G.G.
Keep Off the Grass, New York: Reader's Digest Press (1976).
8.
Nahas G.G. et al.
«Inhibition of Cellular Mediated Immunity in Marihuana Smokers», Science 183: 419—20 (1974).
9.
Nahas G.G.
(1976), см. № 7.
10.
Lau R.J. et al.
«Phytohemagglutinin%Induced Lymphocyte Transformation in Humans Receiving Delta%9%
Tetrahydrocannabinol», Science 192: 805—07 (1976);
White S.C. et al.
«Mitogen%Induced Blastogenetic Responses
to Lymphocytes from Marihuana Smokers», Science 188: 71—72 (1975);
Dax E.M. et al.
«The Effects of 9%ENE%
Tetrahydrocannabinol on Hormone Release and Immune Function», Journal of Steroid Biochemistry 34: 263—70
(1989);
Kaklamani E. et al.
«Hashish Smoking and T%Lymphocytes», Archives of Toxicology 40: 97—101 (1978).
11.
Nahas G.G.
Keep Off the Grass, 5th edition, Middlebury, VT: Eriksson P.S. (1990).
12.
Hollister L.E.
«Marijuana and Immunity», Journal of Psychoactive Drugs 24:159—64 (1992).
13.
Holsapple M.P. et al.
«Molecular Mechanisms of Toxicant%Induced Immuno%suppression: Role of Second
Messengers», Annual Review of Pharmacology and Toxicology 36: 131—59 (1996);
Spector S. et al.
«Delta%9%
Tetrahydrocannabinol Augments Murine Retroviral Induced Immunosuppression and Infection», International Journal
of Immunopharmacology 13: 411—17 (1991);
Klein T.W. et al.
«The Effect of Delta%9%Tetrahydrocannabinol and
11%Hydroxy%Delta%9%Tetrahydrocannabinol on T%Lymphocyte and B%Lymphocyte Mitogen Responses», Journal of
Immunopharmacology 1: 451—66 (1985);
Nahas G.G. et al.
«Natural Cannabinoids: Apparent Depression of Nucleic
Acids and Protein Synthesis in Cultured Human Lymphocytes», pp. 177—203 in Braude M.C., Szara S. (eds)
Pharmacology of Marihuana, New York: Raven Press (1976);
Watzl B. et al.
«Influence of Marijuana Components
(THC and CBD) on Human Mono%nuclear Cell Cytokine Secretion In Vitro», pp. 63—70 in Friedman H. et al. (eds)
Drugs of Abuse, Immunity, and Immunodeficiency, New York: Plenum Press (1991).
14.
Banchereau J et al.
«Inhibitory Effects of Delta%9%Tetrahydrocannabinol and Other Psychotropic Drugs on
Cultured Lymphocytes», pp. 129—44 in Nahas G.G. Paton W.D.M. (eds) Marihuana: Biological Effects, New York:
Pergamon Press (1979);
Nahas G.G. et al.
(1976), см. № 13.
15.
Munson A.E., Fehr K.O.
«Immunological Effects of Cannabis», pp. 257—353 in Fehr K.O. Kalant H. (eds)
Cannabis and Health Hazards, Toronto: Addiction Research Foundation (1983).
16.
Cabral G.A. et al.
«Effect of Delta%9%Tetrahydrocannabinol on Herpes Simplex Virus Type 2 Vaginal Infection
in the Guinea Pig», Proceedings of the Society for Experimental Biology and Medicine 182: 181—86 (1986).
17.
Mishkin E.M., Cabral G.A.
«Delta%9%Tetrahydrocannabinol Decreases Host Resistance to Herpes Simplex
Virus Type 2 Vaginal Infection in the BGC3F1 Mouse», Journal of General Virology 66: 2539—49 (1985).
18.
Silverstein M.J., Lensin P.
«2, 4%Dinitrochlorobenzene Skin Testing in Chronic Marihuana Users», pp.
199—203 in Braude M.C. Szara S. (eds) Pharmacology of Marihuana, New York: Raven Press (1976).
19.
Munson A.E., Fehr K.O.
(1983), см. № 15, p. 338.
20. «Marinol», pp. 2129—31 in Physician's Desk Reference, Forty%Ninth Edition, Montvale, NJ: Medical
Economics (1995).
21. Food and Drug Administration, «Unimed's Marinol (Dronabinol) Gains Indication for Anorexia in AIDS
Patients», Food, Drug, and Cosmetic Reporter. 14 (4 January 1993).
142
Марихуана: мифы и факты
22.
Huber G.L. et al.
«Marijuana: Tetrahydrocannabinol and Pulmonary Antibacterial Defenses», Chest 77:
403—10 (1980).
23.
Cabral G.A. et al.
«Chronic Marijuana Smoke Alters Alveolar Macrophage Morphology and Protein
Expression», Pharmacology Biochemistry and Behavior 40: 643—50 (1991).
24.
Barbers R.G. et al.
«Enhanced Alveolar Monocytic Phagocyte (Macrophage) Proliferation in Tobacco and
Marijuana Smokers», American Review of Respiratory Disease 143: 1092—95 (1991);
Barbers R.G. et al.
«Differential
Examination of Bronchoalveolar Lavage Cells in Tobacco and Marijuana Smokers», American Review of Respiratory
Disease 135: 1271—75 (1987).
25.
Wallace J.M. et al.
«Lymphocytic Subpopulation Profiles in Bronchoalveolar Lavage Fluid and Peripheral
Blood from Tobacco and Marijuana Smokers», Chest 105: 847—52 (1994);
Sherman M.P. et al.
«Marijuana Smoking,
Pulmonary Function, and Lung Macrophage Oxidant Release», Pharmacology Biochemistry and Behavior 40: 663—
69 (1991);
Sherman M.P. et al.
«Effects of Smoking Marijuana, Tobacco or Cocaine Alone or in Combination on DNA
Damage in Human Alveolar Macrophages», Life Sciences 56: 2201—07 (1995).
26.
Nieman R.B. et al.
«The Effect of Cigarette Smoking on the Development of AIDS in HIV%1%Seropositive
Individuals», AIDS 7: 705—10 (1993);
Bushkin S.E. et al.
«Heavy Smoking Increases the Risk of Pneumocystis
Carinii Pneumonia (PCP)», paper presented at the International Conference on AIDS, Amsterdam (1992).
27.
Caiaffa W.T. et al.
«Drug Smoking, Pneumocystis Carinii Pneumonia, and Immunosuppression Increase
Risk of Bacterial Pneumonia in Human Immunodeficiency Virus%Seropositive Injection Drug Users», American Journal
of Respiratory and Critical Care Medicine 150: 1493—98 (1994).
28.
Coates R.A. et al.
«Cofactors of Progression to Acquired Immunodeficiency Syndrome in a Cohort of Male
Sexual Contacts of Men with Immunodeficiency Virus Disease», American Journal of Epidemiology 132: 717—22
(1990);
Kaslow R.A. et al.
«No Evidence for a Role of Alcohol or Other Psychoactive Drugs in Accelerating
Immunodeficiency in HIV%1%Positive Individuals», Journal of the American Medical Association 261: 3424—29 (1989).
29.
McCaffery B.
remarks on C%SPAN (21 December,1996); Drug Enforcement Administration, Drug
Legalization: Myths and Misconceptions, Washington, DC (1994);
Gorman T.J.
Marijuana is NOT a Medicine, Santa
Clarita, CA: California Narcotics Officers' Association (1996); Drug Watch International, By Any Modern Medical
Standard, Marijuana is No Medicine, Omaha (undated); Drug Watch Oregon, Marijuana Research Review (February
1994);
Peterson R.E.
The Marijuana as Medicine Scam, Lansing, MI: Michigan Office of Drug Control Policy (undated).
30.
Chusid M. J. et al.
«Pulmonary Aspergillosis, Inhalation of Contaminated Marijuana Smoke, Chronic
Granulomatous Disease», Annals of Internal Medicine 82: 682—83 (1975).
31.
Sutton S. et al.
«Possible Risk of Invasive Pulmonary Aspergillosis with Marijuana Use During Chemotherapy
for Small Cell Lung Cancer», Drug Intelligence and Clinical Pharmacology 20: 289—90 (1986);
Denning D.W. et al.
«Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome», New England Journal of Medicine 324:
654—62 (1991).
15.
КУРЕНИЕ МАРИХУАНЫ И ЛЕГКИЕ
1. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995), p. 36.
2.
Turner C.E.
The Marijuana Controversy, Rockville, MD: American Council for Drug Education (1981).
3.
Nahas G.G., Pace N.A.
«Marijuana as Chemotherapy Aid Poses Hazards», letter to the editor, New York
Times (4 December 1993), p. 20.
4.
Inaba D.S., Cohen D.E.
Uppers, Downers, All%Arounders: Physical and Mental Effects of Psychoactive
Drugs, 2nd Edition, Ashland, OR: CNS Productions, Inc. (1995), p. 174.
5.
Tomatis L.
(ed), Cancer: Causes, Occurrence and Control, Lyon: International Agency on Cancer (1990);
Department of Health and Human Services, The Health Consequences of Smoking: Chronic Obstructive Lung Disease,
Washington, DC: U.S. Government Printing Office (1984).
6.
Huber G.L. et al.
«Marijuana and Tobacco Smoke: Gas%Phase Cytoxins», Pharmacology Biochemistry and
Behavior 40: 629—36 (1991).
7.
Wu T. et al.
«Pulmonary Hazards of Smoking Marijuana as Compared with Tobacco», New England Journal
of Medicine 318: 347—51 (1988).
8.
Tashkin D.P. et al.
«Effects of Habitual Use of Marijuana and / or Cocaine on the Lung», pp. 63—87 in
Chiang N. Hawkins R.L. (eds) Research Findings on Smoking of Abused Substances, Rockville, MD: National
Institute on Drug Abuse (1990);
Sherrill D.L. et al.
«Respiratory Effects of Non%Tobacco Cigarettes: A Longitudinal
Study in the General Population», International Journal of Epidemiology 20: 132—37 (1991).
143
Литература
9.
Polen M.R.
«Health Care Use by Frequent Marijuana Smokers Who Do Not Smoke Tobacco», Western
Journal of Medicine 158: 596—601 (1993).
10.
Tashkin D.
quoted in Gagnon L. «Marijuana Less Harmful to Lungs than Cigarettes», Medical Post (Quebec)
(6 September 1994).
11.
Tashkin D.P.
«Heavy Habitual Marijuana Smoking Does Not Cause an Accelerated Decline in FEV1 With
Age», American Journal of Respiratory and Critical Care Medicine 155: 141—48 (1997).
12.
Didcott P. et al.
Long%Term Cannabis Users on the New South Wales North Cost, Canberra: Australian
Government Publishing Service (1997).
13.
Glatt H. et al.
«Delta%1 %Tetrahydrocannabinol and 1 Alpha, 2 Alpha%Epoxyhexahydrocannabinol:
Mutagenicity Investigation in the Ames Test», Mutation Research 66: 329—35 (1979);
Zimmerman S., Zimmerman
A.M.
«Genetic Effects of Marijuana», International Journal of the Addictions 25:19—33 (1990—91).
14.
Leuchtenberger C.
«Effects of Marijuana (Cannabis) Smoke on Cellular Biochemistry of In VitroTest Systems»,
pp. 177—224 in Fehr K.O. Kalant K. (eds) Cannabis and Health Hazards, Toronto: Addiction Research Foundation
(1983).
15.
Novotny M. et al.
«Possible Basis for the Higher Mutagenicity of Marijuana Smoke as Compared to Tobacco
Smoke», Experientia 32: 280—82 (1975);
Hoffman D. et al.
«On the Carcinogenicity of Marijuana Smoke», Recent
Advances in Photochemistry 9: 63—81 (1975).
16.
Harvey R.G.
Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity, Cambridge: Oxford
University Press (1991).
17.
Huber G.L. et al.
«The Effects of Marijuana on the Respiratory and Cardiovascular Systems», pp. 3—18 in
Chesher G. et al. (eds) Marijuana: an International Research Report, Canberra: Australian Government Publishing
Service (1988).
18.
Fligiel S.E.G. et al.
«Bronchial Pathology in Chronic Marijuana Smokers: A Light Electron Microscope
Study», Journal of Psychoactive Drugs 20: 33—42 (1988).
19.
Fligiel S.E.G. et al.
«Pulmonary Pathology in Marijuana Smokers», pp. 43—47 in Chesher G. et al. (eds)
Marijuana: An International Research Report, Canberra: Australian Government Publishing Service (1988).
20.
Sridhar K. et al.
«Possible Role of Marijuana Smoking as a Carcinogen in the Development of Lung Cancer
at a Young Age», Journal of Psychoactive Drugs 26: 285—88 (1994).
21. Substance Abuse and Mental Health Services Administration, National Household Survey on Drug Abuse:
Main Findings 1994, Rockville, MD: U.S. Department of Health and Human Services (1996), pp. 46, 49.
22.
Doblin R.
«The MAPS / California NORML Marijuana Waterpipe / Vaporizer Study», Newsletter of the
Multidisciplinary Association for Psychedelic Studies 5, 1: 19—22 (1994).
23.
Agurell S., Leander K.
«Stability, Transfer and Aborption of Cannabinoid Constituents of Cannabis (Hashish)
Smoking», Acta Pharmaceutica Suecica 8: 391—402 (1971);
Zacny J.P., Chait L.D.
«Breathhold Duration and
Response to Marijuana Smoke», Pharmacology Biochemistry and Behavior 33: 481—84 (1989);
Zorilosa J. et al.
«Marijuana Smoking: Effects of Varying Puff Volumes and Breathholding Duration», Journal of Pharmacology and
Experimental Therapeutics 272: 560—69 (1995).
16.
ДЛИТЕЛЬНОЕ НАХОЖДЕНИЕ МАРИХУАНЫ В ОРГАНИЗМЕ
1. Committees of Correspondence, Drug Abuse Newsletter16 (March 1984).
2.
Mann P.
Marijuana Alert, New York: McGraw%Hill Book Company (1985), p. 184.
3.
Nahas G.G.
«When Friends or Patients Ask About Marihuana», Journal of the American Medical Association
233 (1979), p. 79.
4.
DuPont R.
Getting Tough on Gateway Drugs, Washington, DC: American Psychiatric Press, Inc. (1984),
p. 68.
5.
Martin B.R.
«Cellular Effects of Cannabinoids», Pharmacological Reviews 38: 45—74 (1986).
6.
Agurell S. et al.
«Pharmacokinetics and Metabolism of Delta%1%Tetrahydrocannabinol and Other Cannabinoids
with Emphasis on Man», Pharmacological Reviews 38: 21—43 (1986);
Cone E.J. et al.
«Acute Effects of Smoking
Marijuana on Hormones, Subjective Effects and Performance in Male Human Subjects», Pharmacology Biochemistry
and Behavior 24: 1749—54 (1986).
144
Марихуана: мифы и факты
7.
Barnett G. et al.
«Behavioral Pharmacokinetics of Marijuana», Psychopharmacology 85: 51—56 (1985);
Cone E.J., Huestis M.A.
«Relating Blood Concentrations of Tetrahydrocannabinol and Metabolites to Pharmacologic
Effects and Time of Marijuana Usage», Therapeutic Drug Monitoring 15: 527—32 (1993);
Morgan J.P.
«Marijuana
Metabolism in the Context of Urine Testing for Cannabinoid Metabolite», Journal of Psychoactive Drugs 20: 107—
15 (1988).
8.
Swatek, R.
«Marijuana Use: Persistence and Urinary Elimination», Journal of Substance Abuse Treatment 1:
265—70 (1984).
9.
Garrett E.R.
«Pharmacokinetics and Disposition of Delta%9%Tetrahydrocannabinol and its Metabolites»,
Advances in Bioscience 22—23:105—21 (1978).
10.
Hollister L.E.
«Health Aspects of Cannabis», Pharmacological Reviews 38:1—20 (1986).
11.
Moscowitz H. et al.
«Duration of Skills Performance Impairment Under Marijuana», American Association
for Automotive Medicine Proceedings 181: 87—96 (1979);
Chait L.D. et al.
«'Hangover' Effects The Morning After
Marijuana Smoking», Drug and Alcohol Dependence 15: 229—38 (1985);
Yesavage J.A. et al.
«Carry%Over Effects
of Marijuana Intoxication on Aircraft Pilot Performance: A Preliminary Report», American Journal of Psychiatry
142:1325—29 (1985);
Leirer V.O. et al.
«Marijuana Carry%Over Effects on Aircraft Pilot Performance», Aviation,
Space, and Environmental Medicine 62: 221—27 (1991).
12.
Chait L.D.
«Subjective and Behavioral Effects of Marijuana the Morning After», Psychopharmacology 100:
328—33 (1990);
Cocchetto D.M. et al.
«Relationship Between Plasma Delta%9%Tetrahydrocannabinol Concentration
and Pharmacologic Effects in Man», Psychopharmacology 75:158—64 (1981);
Hollister L.E. et al.
«Do Plasma
Concentrations of Delta%9%Tetrahydrocannabinol Reflect the Degree of Intoxication?», Journal of Clinical Pharmacology
21:171—77S (1981);
Lindgren J.C. et al.
«Clinical Effects and Plasma Levels of Delta%9%Tetrahydrocannabinol
(Delta%9%THC) in Heavy and Light Users of Cannabis», Psychopharmacology 74: 802—12 (1981);
PerezReyes M.
et al.
«The Clinical Pharmacology and Dynamics of Marijuana Cigarette Smoking», Journal of Clinical Pharmacology
21: 201—07S (1981);
PerezReyes M. et al.
«Comparison of Effects of Marijuana Cigarettes of Three Different
Potencies», Clinical Pharmacology and Therapeutics 31: 617—24 (1982);
Ohlsson A. et al.
«Plasma Delta%9%
Tetrahydrocannabinol Concentrations and Clinical Effects After Oral and Intravenous Administration and Smoking»,
Clinical Pharmacology and Therapeutics 28: 409—16 (1980);
Leirer V.O. et al.
«Marijuana, Aging, and Task Difficult
Effects on Pilot Performance», Aviation, Space, and Environmental Medicine 60:1145—52 (1989);
Janowsky D.S.
et al.
«Marijuana Effects on Simulated Flying Ability», American Journal of Psychiatry 133: 384—88 (1976);
Cone E.I.
et al.
(1986), см. № 6.
13.
Hollister L.E.
(1986), см. № 10.
14.
Kreuz D.S., Axelrod J.
«Delta%9%Tetrahydrocannabinol: Localization in Body Fat», Science 179: 391—92
(1973);
Johansson E. et al.
«Analysis of Delta%1%Tetrahydrocannabinol (Delta%1%THC) in Human Plasma and Fat
After Smoking», pp. 291—96 in Chesher E. et al. (eds) Marijuana: An International Report, Canberra: Australian
Government Publishing Service (1988).
15.
Siegel G.J. et al.
Basic Neurochemistry, New York: Raven Press (1989).
16.
Ryrfeldt A.
«Whole Body Autoradiography of Delta%1%Tetrahydrocannabinol and Delta%6%Tetra%
hydrocannabinol in Mouse», Acta Pharmaceutica Suecica 10: 13—28 (1973);
Nahas G. et al.
«The Kinetics of
Cannabinoid Distribution and Storage with Special Reference to the Brain and Testes», Journal of Clinical Pharmacology
21: 208—14S (1981);
Bronson M. et al.
«Distribution and Disposition of Delta%9%Tetrahydrocannabinol (THC) in
Different Tissues of the Rat», pp. 309—17 in Agurell S. et al. (eds) The Cannabinoids: Chemical, Pharmacologic, and
Therapeutic Aspects, Orlando: Academic Press (1984);
Kreuz D.S., Axelrod J.
(1973) см. № 14.
17.
Hollister L.E.
(1986), см. № 10.
18.
Morgan J.P.
«Urine Testing for Cannabinoid Metabolite; Technical and Practical Problems», pp. 333—44
in Chesher G. et al. (eds) Marijuana: An International Report, Canberra: Australian Government Publishing Service
(1988).
17.
МАРИХУАНА И БЕЗОПАСНОСТЬ ДОРОЖНОГО ДВИЖЕНИЯ
1. Center on Addiction and Substance Abuse, Legalization: Panacea or Pandora's Box, New York (1995), p. 36.
2. Neil Swan, «A Look at Marijuana's Harmful Effects», NIDA Notes 9, 2 (1994), p. 14.
3.
Moskowitz H., Petersen R.
Marijuana and Driving: A Review, Rockville, MD: American Council for Drug
Education (1982), p. 7.
4.
Mann P.
Marijuana Alert, New York: McGraw%Hill (1985), p. 265.
145
Литература
5.
Jacobs J.B.
Drunk Driving: An American Dilemma, Chicago: University of Chicago Press (1989).
6. National Commission on Marihuana and Drug Abuse, Marihuana: A Signal of Misunderstanding, Washington,
DC: U.S. Government Printing Office (1972).
7.
Robbe H., O'Hanlon J.
Marijuana and Actual Driving Performance, Washington, DC: Department of
Transportation (1993), p. 107.
8.
Moskowitz H.
«Marijuana and Driving», Accident Analysis and Prevention 17: 323—45 (1985).
9.
Stein A.C. et al.
A Simulator Study of the Combined Effects of Alcohol and Marijuana on Driving Behavior;
Phase II, Washington, DC: U.S. Department of Transportation (1983);
Hansteen R.W. et al.
«Effects of Cannabis
and Alcohol on Automobile Driving and Psychomotor Tracking», Annals of New York Academy of Sciences 282:
240—56 (1976);
Moskowitz H. et al.
«Marihuana: Effects on Simulated Driving Performance», Accident Analysis
and Prevention 8:45—50 (1976);
Crancer A. et al.
«Comparison of the Effects of Marihuana and Alcohol on Simulated
Driving Performance», Science 164: 851—54 (1969).
10.
Klonoff H.
«Marijuana and Driving in Real%Life Situations», Science 186: 317—24 (1974);
Sutton L.R.
«The
Effects of Alcohol, Marijuana and Their Combination on Driving Ability», Journal of Studies on Alcohol 44: 438—45
(1983);
Peck R.C. et al.
«The Effects of Marijuana and Alcohol on Actual Driving Performance», Alcohol, Drugs and
Driving 2: 135—54 (1986);
Hansteen R.W. et. al.
(1976), см. № 9.
11.
Smiley A.
«Marijuana: On%Road and Driving Simulator Studies», Alcohol, Drugs and Driving 2: 121—34
(1986);
Chesher G.B.
«Cannabis and Road Safety: An Outline of the Research Studies to Examine the Effects of
Cannabis on Driving Skills and On Actual Driving Performance», pp. 67—96 in Inquiry into the Effects of Drugs
(Other than Alcohol) on Road Safely in Victoria, Report of the Parliament of Victoria, Melbourne: Government Printer
(1995);
Dott A.B.
Effect of Marihuana on Risk Acceptance in a Simulated Passing Task, Rockville, MD: U.S.
Department of Health, Education, and Welfare (1972);
Moskowitz
H. (1985), см. № 8.
12.
Robbe H., O'Hanlon J.
(1993), см. № 7.
13.
Mathias R.
«Marijuana Impairs Driving%Related Skills and Workplace Performance», NIDA Notes 11,1: 6 (1996).
14.
Moskowitz H., McGlothlin W.
«Effects of Marihuana on Auditory Signal Detection», Psychopharmacology
40: 137—40 (1974);
Moskowitz H. et al.
(1976), см. № 9.
15.
Barnett G. et al.
«Behavioral Pharmacokinetics of Marijuana», Psychopharmacology 85: 51—56 (1985);
Smiley A.
(1986), см. № 11.
16.
Martin B.R.
«Cellular Effects of Cannabinoids», Pharmacological Reviews 38: 45—74 (1986).
17.
McBay A.J., Owens S.M.
«Marijuana and Driving», pp. 257—63 in Harris L.S. (ed) Problems of Drug
Dependence 1980, Washington, DC: U.S. Government Printing Office (1981);
Terhune K.W. et al.
The Incidence
and Role of Drugs in Fatally Injured Drivers, Washington, DC: Department of Transportation (1992);
Cimbura G. et
al.
«Incidence and Toxicological Aspects of Drugs Detected in 484 Fatally Injured Drivers and Pedestrians in Canada»,
Journal of Forensic Sciences 27: 855—67 (1982);
Mason A.P, McBay AJ.
«Ethanol, Marijuana, and Other Drug Use
in 600 Drivers Killed in Single—Vehicular Crashes in North Carolina», Journal of Forensic Sciences 29: 987—1026
(1984);
Crouch D.J. et al.
«The Prevalence of Drugs and Alcohol in Fatally Injured Truck Drivers», Journal of Forensic
Sciences 38: 1342—53 (1993);
Drummer O.H.
«A Review of the Contribution of Drugs in Drivers to Road Accidents»,
pp. 1—28 in Inquiry into the Effects of Drugs (Other than Alcohol) on Road Safety in Victoria, Report of the Parliament
of Victoria, Melbourne: Government Printer (1995);
Cimbura G. et al.
«Incidence and Toxicological Aspects of
Cannabis and Ethanol in 1394 Fatally Injured Drivers and Pedestrians in Ontario (1982—1984)», Journal of Forensic
Sciences 35: 1035—41 (1990).
18.
Terhune K.
The Role of Alcohol, Marijuana and Other Drugs in the Accidents of Injured Drivers, Washington,
DC: Department of Transportation (1982).
19.
Williams A. et al.
«Drugs in Fatally Injured Young Male Drivers», Public Health Reports 100: 19—25
(1985);
Terhune K.W. et al.
(1992), см. № 17;
Drummer O.H.
(1995), см. № 17.
20.
Drummer O.H.
(1995), см. № 17, p 13.
21.
Chait L.D, Pierri J.
«Effects of Smoked Marijuana on Human Performance: A Critical Review», pp. 387—
424 in Murphy L, Bartke A. (eds) Marijuana / Cannabinoids: Neurobiology and Neurophysiology, Boca Raton: CRC
Press (1992).
22.
Ellingstad, V.S. et al.
Alcohol, Marihuana, and Risk Taking, Washington, DC: National Highway Traffic
Safety Administration (1973);
Stein A.C. et al.
(1983), см. № 9;
Dott A.B.
(1972), см. № 11.